ArticleRheumatology (Oxford, England)2025
Tocilizumab discontinuation after remission achievement in patients with adult-onset Still's disease.
Hiroya Tamai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it